Abstract
944P - QUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have